经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)_第1页
经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)_第2页
经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)_第3页
经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)_第4页
经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)_第5页
已阅读5页,还剩48页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

IntroductionTreatmentofsymptomaticpatientswithHOCMaimstoreducesymptoms,improvefunctioncapacityandprovidebetterqualitylife.AimsdirectlytoreducethehypertrophiedinterventricularseptumwithconsecutiveexpansionoftheLVoutflowtractandreductionoftheLVoutflowtractgradientandimprovedistolicfunctionLV.Firstchoicedrugestreatment.

Atleast

10%

ofpatientswithmarkedoutflowtractobstructionhaveseveresymptoms,whichareunresponsivetomedicaltherapy.HOCMMyectomyDDD-PMICDPTSMAIntroductionTreatmentofsympt1HypertrophiccardiomyopathyEpidemiologicalcharacteristicsHypertrophiccardiomyopathyincidenceof0.2%(1:500),0.16%inourcountry

.Thevastmajorityofpatientswithnosymptoms,

25%ofoutflowtractobstructionoccurredonlyabout5-10%ofpatientswithdrugtreatmentsfailorcauseserioussideeffectsofdrugseffectivedose.Requiretreatmentorsurgicalinterventioninpatientstreatedwithonlyveryfewparts.

HypertrophiccardiomyopathyEp2PathophysiologicandclinicalcharacteristicsofHOCM

VentricularhypertrophyLeftventricularoutflowtractpressuregradientMyocardialischemia-anginapectoris.Arrhythmia-ventriculartachycardia,fibrillation.Clinicalmanifestations:dizziness,amaurosis,syncope,exertionalshortnessofbreath,anginapectoris,heartdisfunctionandsuddendeath.Generallyconsidered:moreseverehypertrophy,outflowtractobstructionneartheLVOTsit,themorehighertheobstructivepressuregradientwerethemoreobviousclinicalsymptomsandthegreaterthepotentialthreat.Pathophysiologicandclinical3ThenaturalcourseofoutflowtractobstructionLevel–anyages.thereisabigdifferenceinNaturalhistoryThenaturalcoursenotsure.Themorecardiachypertrophy,thehigherthepressuregradient,thegreatertheriskofsuddendeath.

Theoutflowtractpressuregradientoftheclinicalimportanceoftheissueremainscontroversial,butitisgenerallyconsideredanimportantclinicalprocessindicators.Nnualmortalityrateof2-4%,theincidenceof

suddendeath≤1%

Thenaturalcourseofoutflow4Thesymptoms

Whethertheobstructionproducedtheclinicalsymptoms?notonlywiththedegreeofoutflowtractobstructionandoutflowtractpressuregradient,aswellastheobstructionsite.Butalsowithventriculardiastolicfunctionandtheadequacyofvenousreturnisalsocloselyrelated.Increasetheheartbeforeandafterloadandmyocardialcontractilityoftencausenoticeableclinicalsymptoms.Therefore,itwillbecomemoreapparentafterexercise.Thepatientsshouldbetreatment.ThesymptomsWhethertheobs5Diastolicdysfunction

Allpatientshaddiastolicdysfunction–HowthepressuregradientandsymptomsAndtheextentanddistributionofthehypertrophyhasnothingtodo.Whethernormalorsmallventricularcavity,duetoincreasedheartweight,ventricularvolumereduction,myocardialfibrosis,leavingventricularstiffnessincreased,compliancedecreasedandcausedthediastolicfunctiondamage.Pulmonaryvenouspressureandend-diastolicpressure

wereincreasedandheartdisfunction.DiastolicdysfunctionAllpati6systolicfunctionSystolicfunctionisnormalorsupranormalinHCOMBothobstructionandnon-obstruction,Systolicdysfunctionoccursinsmallsubset(10-15%)

Resultofprogressiveimpairmentofsystolicfunction.Thistransformation:wallthinning,cavitydilation,andfibrosis,increasedmortality11%(annual)andriskofSCD.ConventionalUCG,M-mode,orEF,fractionalshorteningpreserveddespiteimpaimentlong-axisfunctionTissueDopplerimage(TD)-derivedsystolicvelocities:inthebasalinferoseptalandanterolateralwallroutinelyinallpatientsonsubsequentscans.systolicfunctionSystolicfunc7PTSMAindication(1)ClinicalindicationNodobutaminegradients(Drugs)CoronaryangiographyVerapamilRemoveballoonshouldbeemptyingalcoholoftheballooncatheterandstagnationinjectionalcoholOutflowtractobstructionsign

inEchocardiographSeptalthicknessHypertrophicCardiomyopathy

SurvivalAccordingtoOutflowTractGradientSystolicfunctionisnormalorsupranormalinHCOMMCEMorophologicindicationBeta-blockersasymmetricalseptalhypertrophy(ASH),2.Targetvesselsupplytonon-obstructionotherregionssuchas:papillarymuscle,freewall,etc.CONCLUSIONSBeta-blockersCONCLUSIONSCharacteristicsHypertrophiccardiomyopathyEpidemiologicalcharacteristicsMyocardialischemiaMyocardialischemia,thesymptomsofanginapectorisare:High-powersothatleftventricularmyocardialoxygenconsumptionincreased;Cardiaccontractionstrengthofoppressionthelargemyocardialcoronaryartery;Intramyocardialsmallcoronaryarterystenosisandintimalthickeningabnormalities,leadingtocardiachypertrophyandcoronaryarteryoxygenrequiredduetoanimbalanceofoxygensupply.PTSMAindication(1)Myocardia8Arrhythmiaandsuddendeath

HOCMofpatientswithabnormalmyocardialcellsandthearrangementofdisorderprovidesabasisforthearrhythmia.However,abnormalmyocardialarrangementandspontaneousarrhythmiasandventricularfibrillationthreshold,thepreciserelationshipisunclear.About25%ofpatientsmayhavenon-sustainedventriculartachycardia,thearrhythmiaissuddendeathofagoodpredictor,andnegativepredictiveaccuracyis97%.

ArrhythmiaandsuddendeathHO9RiskfactorsforsuddendeathHigh-risk:

1Suddendeathoccurredinasuccessfulrescue

2continuousmonomorphicventriculartachycardia

Clinicalriskfactors:

1non-sustainedventriculartachycardia

2movementabnormalbloodpressureresponse(≥25mmHg)

3unexplainedsyncope

4early-onsetfamilyhistoryofsuddendeath

5severeleftventricularhypertrophy>30mm

Riskfactorsforsuddendeath10ThepurposeofthetreatmentPTMSA

TreatmentofsymptomaticpatientswithHOCMThePTMSAtreatmentofHOCMisaobstructionbyblockingathesupplybloodofpartsoftheseptalhypertrophyofmyocardialandmyocardialinjuryintheregion,leadingtotheareaofmyocardialnecrosis,myocardialcontractilefunctiondisappeared,Widenedtheleftventricularoutflowtract,whileloweringtheoutflowtractobstructionandthecardiacoutputincrease.Andimproveclinicalsymptomsandhemodynamics.ThepurposeofthetreatmentP11PTSMAindication(1)ClinicalindicationSymptomaticpatientsDrugrefractoryseveresaideffectsmedicaltreatmentFunctionalclassIIIorIVFunctionalclassIIwithobjectivelimitationorriskfactorsRecurrentexercise-inducedsyncopesFailureofpriormyectomyorDDD-PMComorbitiywithincreasedsurgicalrisk.PTSMAindication(1)Clinical12PTSMAindication(2)HemodynamicindicationinsymptomaticpatientsThepressuregradientatrest>50mmHgor>100mmHgwithprovocation.In2008ESCmeeting,SeggewisethatLVgradient≧30mmHgatrestorProvocableLVgradient≧60mmHg.ValsalvaPostextrasystole.Nodobutaminegradients(Drugs)

(ThereisnoinformationthatreducetheLVOTpressuretoreducesuddendeath,buttheLVOT>30mmHgandincreasedriskofdeathdirectlyrelatedto,NewEnglJMed2003;348:295-303)

PTSMAindication(2)Hemodynam13HypertrophicCardiomyopathy

SurvivalAccordingtoOutflowTractGradientBJMaronetal;JAMA281:650-655,1999HypertrophicCardiomyopathy

S14PTSMAindication(3)MorophologicindicationEchocariography

SubaorrticSAM-associatedgradientMid-cavitarygradientCaution:papillarymuscleinvolvement:MCENoprolongedmitralleafletsCoronaryangiographysuitableseptalbranch.PTSMAindication(3)Moropholog15Outflowtractobstructionsign

inEchocardiographM-modeechocardiograminobstructivehypertrophiccardiomyopathyshowingsystolicanteriormotionofthemitralvalve(SAM)(arrowsindicatingseptumandmitralvalveleafletcontact)Outflowtractobstructionsign16

MorphologicofHOCMNewclassficationofHOCMMethods:theywereclassifiedinto4typesaccordingtotheechocardiographicresults:TypeI:localsubaorticobstructionofHOCM;TypeII:predominantinmidventicularobstruction;TypeIII:diffuseseptalhypertrophicobstructioninoutflowtractandmidventicularobstruction;TypeIV:multipositionhypertrophicobtruction.1.asymmetricalseptalhypertrophy(ASH),2.Idiopathichypertrophicsubaorticstenosis(IHSS),3.ApicalorJapaneseHCM.InthisformofnonobstructiveHCM,thethickestpartoftheleftventricleisatthetiporapexofthepump.4.theobstructionisnotintheoutflowtractbutinthemiddleoftheventricle.Atunnelleadsintoadilatedapicalportion,calledananeurysm,whichhasthinwalls.MorphologicofHOCM17OurclassficationinPTSMAOurtypingintheI-typeandMaronintheI-typingwasthesameassuitableforPTSMAtreatmentandMaron'sII-typeincludesthetypeIIandtype

IIIofourmodel,itissuitablePTSMAtreatment.Therefore,ourIV-typeclassificationisthefirstmadebyultrasoundimagingfeaturesofHOCM,accordingtoitscharacteristicsinlinewithPTSMAtreatment.OurclassficationinPTSMAO18ArrhythmiaandsuddendeathClinicalindicationSeptalAblationinHOCM

AcuteResults/AblationTechniquePathophysiologicandclinicalcharacteristicsofHOCMCharacteristics(post-PTSMA6months)Thevesselcannotthoroughorincompleteablation(remainingsmallerbranches),self-revascularization.SeptalthicknessCharacteristicsTransitorytrifascicularblocksoccurredatarateof52.(PG=80mmHg)DiltiazemThevesselcannotthoroughorincompleteablation(remainingsmallerbranches),self-revascularization.ResultsofPTSMASeptalthicknessHypertrophicCardiomyopathy

SurvivalAccordingtoOutflowTractGradientIncreasetheheartbeforeandafterloadandmyocardialcontractilityoftencausenoticeableclinicalsymptoms.Complicationsinourpatientsasymmetricalseptalhypertrophy(ASH),2.Mergeotherneedssurgeryheartdisease

Mitralvalveabnormalitiesandtheirownformofpapillarymusclesinvolvedintheformationofpressuregradient,ormitralvalveprolapseandregurgitation.PTSMAcontraindicationsTarget

vessel

Selectablationofregionalimportance,particularlyinthetargetvesselisnotclearwhotheseptalbranch

Thefirstseptalbranchofthesizeanddistributionaregreatvariation

20%ofpatientsfirstbranchwassuppliedthefreewallofrightventricle

40%ofpatientswithsubaorticofseptalisnotcompletelysupportedbythefirstseptalbranch

5%ofpatientscannotdeterminethetargetvesseloftheregionArrhythmiaandsuddendeathTar19Contrastechocardiographymethod

inthetargetvesse

choiceInjectionofasmallamountofdye(1-2ml)throughtheguidewirelumenoftheinflatedballooncatheterangiographicallyPriortoalcoholinjection1-2mlofechocontrastmediumisadministeredthroughthecentrallumenoftheballooncatheterunderUCG.determinesthesupplyareaofthetargetseptalbranch.Ensurethatnoareasinvolvingnon-obstructive,suchasthepapillarymusclesandventricularfreewallandotherparts.Contrastechocardiographymeth20Myocardial-Contrast-Echo

inHOCM

AvoidLADballooningExcludeLADleakageMyocardial-Contrast-Echoi21SeptalAblationinHOCM

Myocardial-Contrast-EchoLevovist

Intheintervalofcontrastagentinjectedintothebranchtoobservethedistributionofvascularcontr

Alcohol

ShadowSeptalAblationinHOCM

Myocar22

LevovistshadowLevovistshadow23Echosequence:SubaorticseptumastargetbregionintypicalSAM-associated,subaorticobstraction,(Ddottedline),EtestinjectionoftheechocontrastagentinballoonofthethefirstsetalbranchofaforwardbranchofpositionhighlightingbebasalhalfofseptumplusaRVpapillarymuscle(whitearrows).Aftersuper-selectiveballoonofotherbranchoffirstseptalbranch.Correctopacification.Echosequence:Subaorticseptu24MCEN=222NoMCEn=30PSeptalbranches(n)1.0±0.11.3±0.2<0.0001Alcohol(ml)2.9±0.93.9±2.4<0.0001Balloonsize(mm)1.9±0.42.4±0.2<0.0001CKmax(U/l)534±248745±420<0.001CK-MBmax(U/l)62±3096±62<0.0001H.Seggewissetal,49thScientificSessionsACC,2000SeptalAblationinHOCM

AcuteResults/AblationTechniqueMCENoMCEPSeptalbranches(n)125H.Seggewissetal,49thScientificSessionsACC,2000SeptalAblationinHOCM

AcuteResults/AblationTechniquep<0.05p<0.01H.Seggewissetal,49thScien26keysofTechnologyofPTSMA

Thekeytechnology:

identificationThepressuregradientatsubaorticandleftventricularidentificationsuitableoftargetseptalbranches.Mustbeinsertedtemporarypacemaker(topreventtheconductionblock).

Simultaneousmonitoringofaorticandleftventricularpressure.

Heparin(topreventcatheterinducedthrombosis).

AnalgesicGuidingcatheter:supportingflexibleandlowinjurySuitableOver-the-wireballooncatheterkeysofTechnologyofPTSMATh27ThekeysofTechnology

PTSMAIntraoperativeultrasoundmonitoringContrastechocardigraphyPaycloseattentiontothepressuregaugeunderfluoroscopy(observationballoonexpansionofstate).Injectionofalcoholdoseandspeeddeterminewhethershouldinjury(catheteroralcohol)andtheintervalbranchblock(necrosisstate)conditions1(withcomplications)or2septalbranches

ablationdidnotsignificantlyreducethepressure,andnoincreasealcoholdoseRemoveballoonshouldbeemptyingalcoholoftheballooncatheter

andstagnationinjectionalcoholThekeysofTechnologyPTSMAIn28(pre-PTSMA)Septalthickness(post-PTSMA3days)Mid-cavitarygradientTargetvesselsupplytonon-obstructionotherregionssuchas:papillarymuscle,freewall,etc.Priortoalcoholinjection1-2mlofechocontrastmediumisadministeredthroughthecentrallumenoftheballooncatheterunderUCG.Outflowtractobstructionsign

inEchocardiographAcutemitralregurgitationalsodidnotoccur.CONCLUSIONS43monthslater,90%ofthepatientsofthepressuregradientcompletelyeliminatedbyechocardiographic5mmandtoolong.MorphologicofHOCMTransitorytrifascicularblocksoccurredatarateof52.EchocariographyClinicalmanifestations:dizziness,amaurosis,syncope,exertionalshortnessofbreath,anginapectoris,heartdisfunctionandsuddendeath.Contrastechocardiographymethod

inthetargetvessechoiceClinicalindicationOutflowtractobstructionsign

inEchocardiographResultsofPTSMASystolicfunctionisnormalorsupranormalinHCOMSeptalthicknessContrastechocardigraphyAvoidLADballooningHypertrophiccardiomyopathyEpidemiologicalcharacteristicsContrastechocardiographycannotdeterminetargetvesselortheobstructionofregionalnosuitabletargetvessel.Doseofalcoholandspeed.(ThereisnoinformationthatreducetheLVOTpressuretoreducesuddendeath,buttheLVOT>30mmHgandincreasedriskofdeathdirectlyrelatedto,NewEnglJMed2003;348:295-303)FunctionalclassIIIorIVdeterminesthesupplyareaofthetargetseptalbranch.DDD-pacemaker:2-10%ResultsofPTSMAComplicationsinourpatientsApicalorJapaneseHCM.CharacteristicsThevesselcannotthoroughorincompleteablation(remainingsmallerbranches),self-revascularization.MorophologicindicationSystolicfunctionisnormalorsupranormalinHCOMThemorecardiachypertrophy,thehigherthepressuregradient,thegreatertheriskofsuddendeath.HypertrophicCardiomyopathy

SurvivalAccordingtoOutflowTractGradientClinicalindicationMustbeinsertedtemporarypacemaker(topreventtheconductionblock).(pre-PTSMA)A51-year-oldwoman’sLVOTgradientwasmonitoredcontinuouslyjustbeforetheballoonocclusion.(PG=80mmHg)LVAO(pre-PTSMA)Contrastechocardig29HerLVOTgradient10minutesafterseptalablation(PG=12mmHg)LVAOHerLVOTgradient10minutesa30A36-year-oldman’sLVOTgradienttestedbyDopplerechocardiographybeforePTSMA(PG=219mmHg)A36-year-oldman’sLVOTgradi31HisLVOTgradient6monthsafterPTSMA(PG=15mmHg)HisLVOTgradient6monthsaft32经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)33经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)34经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)35PG120mmHgbeforeprocedurePG120mmHgbeforeprocedure36PG=40mmHgafterinjectionof4.8mlalchoholPG=40mmHgafterinjectionof437GreatattentionEchocardiographyshowedventricularseptalhypertrophyover30mminHOCM,necessarytoperformeingPTSMAshouldbeverycautiousandcareful.Maybetherewereathickseptalbranch,andcontrolwide,and

collateral-richseptalbranchofsupport,treatmenthadahigherriskandimprovetheclinicalsymptomsandhemodynamicshavedifficulties,sosurgerymytomcemaybeabetterchoice.GreatattentionEchocardiog38Itisverybigseptalbranch>2.5mmandtoolong.ThereisquitedangertoPTMSAItisverybigseptalbranch>39PTSMAcontraindications

Nosignificantpressuregradientinhypertrophiccardiomyopathyorverydiffuseobstructive.

Mergeotherneedssurgeryheartdisease

Mitralvalveabnormalitiesandtheirownformofpapillarymusclesinvolvedintheformationofpressuregradient,ormitralvalveprolapseandregurgitation.

Contrastechocardiographycannotdeterminetargetvesselortheobstructionofregionalnosuitabletargetvessel.

Targetvesselsupplytonon-obstructionotherregionssuchas:papillarymuscle,freewall,etc.

NotsuitableOver-the-wireballoon.PTSMAcontraindicationsNosig40PTSMAcomplications(1)

Hospitalmortalityrate:1-2%DDD-pacemaker:2-10%

Myocardialinfarction

Reason:alcoholleakageintothepartsofinappropriate,collateralbranchopening,alcoholintotheinappropriatepartscauseno-reflow,LAD/LM/RCAinjury

Emergencysurgery

Reason:coronaryarteryinjury,acutemitralregurgitation(papillarymusclerupture)Bundlebranchblock:about50%andRBBB-basedPTSMAcomplications(1)Hosp41PTSMAcomplications(2)

HeightorIII°-AVB

Factors:

whetherthemethodofapplicationofmyocardialcontrastechocardiography.

Doseofalcoholandspeed.Leftanteriordescendingarterydissection,coronarythrombosis,ventricularfibrillationandventriculartachycardia,acutemitralregurgitation,rightventricularinfarction,leftventricularfreewallinfarction.PTSMAcomplications(2)Heig42PTSMAshortcomings

Injuryoftheleftcoronaryarteryrequiredemergencybypassorstent

Cannotenterthetargetseptalbranch

CannotdeterminethetargetbranchofsupportFormitralandpapillarymuscleanomaliesandabnormalseptalhypertrophythebestchoicethesurgery

Mitralvalveinjuryrequiredemergencysurgery.

PermanentconductionblockoccurstreatmentshouldbePMPTSMAshortcomingsInjuryoft43Theseptalbranchwithgoodcollateralcirculation.DiastolicdysfunctionBeta-blockersThevastmajorityofpatientswithnosymptoms,PTSMAcomplications(2)(post-PTSMA3days)PTSMAindication(3)EchocardiographicobservationsplaysanimportantroleinthatwillhelptofinalizedefinethechoiceofseptalablationandtheablationefficacyandreducerisksandLong-termfollow-upoftreatmentefficacy.ComplicationsinourpatientsPG120mmHgbeforeprocedureFunctionalclassIIwithobjectivelimitationorriskfactorsClinicalindicationPatients(n=171)EchocariographyGenerallyconsidered:moreseverehypertrophy,outflowtractobstructionneartheLVOTsit,themorehighertheobstructivepressuregradientwerethemoreobviousclinicalsymptomsandthegreaterthepotentialthreat.DiltiazemHOCMMyectomyFormitralandpapillarymuscleanomaliesandabnormalseptalhypertrophythebestchoicethesurgery59%)underwentpermanentpacemakerimplantationduetopermanentcompleteAVblock.VerapamilMyocardial-Contrast-EchoinHOCMHerLVOTgradient10minutesafterseptalablation(PG=12mmHg)PTSMAlimitations

Someyoungpatientstoreducethepressuregradienteffectisnotsatisfactory,thepossiblereasons:Theseptalbranchwithgoodcollateralcirculation.Thevesselcannotthorough

orincompleteablation(remainingsmallerbranches),self-revascularization.Ahigherdegreeofseptalhypertrophy,ahigherdegreeoffibrosis,Partsoftheseptalablationscarformationpoor.

Theseptalbranchwithgoodco44PTSMAin

FuwaiHospitalFromDec2000toMay2009,171patientsunderwentPTSMAinFuwaiHospital.Proceduresuccesswasachievedin141patients,successratewas82.6%.PTSMAin

FuwaiHospitalFrom45PatientCharacteristicsCharacteristicsPatients(n=171)Age(yrs)45.37±17.71Men/women122/49(71.35%/28.65%)SymptomsDyspnea93(54.39%)Angina73(42.69%)Syncope76(44.44%)NYHAfunctionalclass(II/III/IV)136(79.53%)/32(18.72%)/3(1.75%)Familyhistory42(24.6%)MedicationBeta-blockers106(62%)Verapamil52(30.4%)Diltiazem38(22.2%)Amiodanone13(7.6%)PatientCharacteristicsCharact46ResultsofPTSMAPTSMA(n=171)pSeptalthickness(pre-PTSMA)22.67±5.35mm

Septalthickness(post-PTSMA3days)20.68±4.61mmNSSeptalthickness(post-PTSMA6months)16.77±4.39mm<0.05LVOTPG(pre-PTSMA)97.58±38.23mmHgLVOTPG(post-PTSMA3days)52.36±35.7mmHg<0.001LVOTPG(post-PTSMA6months)47.26±38.62mmHg<0.001LADiameter(pre-PTSMA)43.78±7.33mm

LADiameter(post-PTSMA3days)42.41±7.52mmNSLADiameter(post-PTSMA6months)32.76±15.58mm<0.05ResultsofPTSMAPTSMA(n=171)p47ComplicationsinourpatientsIn-hospitaldeath

UptoMay2009,twopatientsdiedinthose171patients(1.17%)whounderwentPTSMAinFuwaiHospital.OnewasbecauseofalcoholleakagetotheLeftanteriordecendingartery,anotheroccurreddrug-inducedliverinjury.CompleteheartblockTransitorytrifascicularblocksoccurredatarateof

52.05%(89patients).

Onlyonepatient(0.59%)underwentpermanentpacemakerimplantationduetopermanentcompleteAVblock.ComplicationsinourpatientsI48ComplicationsinourpatientsOnepatient(0.59%)occurredventricularfibrillation,butherecoveredwellaftertheprocedure.Rightbundlebranchblockoccurredatarateof48.54%(83in171patients).NodissectionsoftheLMandLAD.NoemergencyCABGAcutemitralregurgitationalsodidnotoccur.ComplicationsinourpatientsO49Follow-upinourpatientsbyecho

Leftventricularoutflowtractpressuregradientwascontinuedtoasignificantdecreaseisanimportantfeature:Comparedwiththeacutephase,56%ofpatients3monthsrestingandstimulatethepressuregradientwillcontinuetodeclinefurther;Comparedwith3-monthperiod,43%ofpatientsoneyearthepressuregradientisstillfurtherreduced.After

3months40%ofpatientswithpressuregradientcompletelyreduced,ayearlaterthisvaluewaspromotedto62%.43monthslater,90%ofthepatientsofthepressuregradientcompletelyeliminatedbyechocardiographicFollow-upinourpatientsbye50CONCLUSIONSPTSMAisaneffectivenon-surgicalprocedureforsymptomaticpatientsandassociatedwithLVOTOinHOCMbecauseofitslowriskanditssignificanthemodynamicandsymptomaticimprovement.Ablationareashouldbeappropriate,assmallaspossible,toavoidalargescarformation.EchocardiographicobservationsplaysanimportantroleinthatwillhelptofinalizedefinethechoiceofseptalablationandtheablationefficacyandreducerisksandLong-termfollow-upoftreatmentefficacy

.CONCLUSIONSPTSMAisaneffecti51Advice

Whohavenosymptomsormildsymptomsofthepatient,determinednottoconsiderthelinetoreduceoutflowtractobstructionofanytherapeuticinterventionmeasures(includingsurgicalandinterventionaltreatment)!!!AdviceWhohavenosymptoms52经皮间隔支化学消融治疗肥厚梗阻性心肌病英文课件(模板)53PTSMAindication(1)ClinicalindicationSymptomaticpatientsDrugrefractoryseveresaideffectsmedicaltreatmentFunctionalclassIIIorIVFunctionalclassIIwithobjectivelimitationorriskfactorsRecurrentexercise-inducedsyncopesFailureofpriormyectomyorDDD-PMComorbitiywithincreasedsurgicalrisk.PTSMAindication(1)Clinical54PTSMAindication(2)HemodynamicindicationinsymptomaticpatientsThepressuregradientatrest>50mmHgor>100mmHgwithprovocation.In2008ESCmeeting,SeggewisethatLVgradient≧30mmHgatrestorProvocableLVgradient≧60mmHg.ValsalvaPostextrasystole.Nodobutaminegradients(Drugs)

(ThereisnoinformationthatreducetheLVOTpressuretoreducesuddendeath,buttheLVOT>30mmHgandincreasedriskofdeathdirectlyrelatedto,NewEnglJMed2003;348:295-303)

PTSMAindication(2)Hemodynam55HypertrophicCardiomyopathy

SurvivalAccordingtoOutflowTractGradientBJMaronetal;JAMA281:650-655,1999HypertrophicCardiomyopathy

S56A36-year-oldman’sLVOTgradienttestedbyDopplerechocardiographybeforePTSMA(PG=219mmHg)A36-year-oldman’sLVOTgradi57PTSMAcontraindications

Nosignificantpressuregradientinhypertrophiccardiomyopathyorverydiffuseobstructive.

Mergeotherneedssurgeryheartdisease

Mitralvalveabnormalitiesandtheirownformofpapillarymusclesinvolvedintheformationofpressuregradient,ormitralvalveprolapseandregu

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论